XRTX
NASDAQ · Pharmaceuticals
Xortx Therapeutics Inc
$2.08
+0.02 (+0.97%)
Analyst Consensus
Strong Buy
5
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,950.0% upside
Low Target
$28.32
Average Target
$42.64
High Target
$47.79
Current Price
$2.08
Current
$2.08
$2.08
Target
$42.64
$42.64
$28.32
$42.64 avg
$47.79
Scenario Analysis
Bear Case
$28.32
1,261.5%
Low target
Base Case
$42.64
+1,950.0%
Avg target
Bull Case
$47.79
+2,197.6%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$9.85
-78.9% from high
52-Week Low
$2.42
+-14.0% from low
Target vs 52W High
$42.64
+332.9% vs high
Peer Consensus — Pharmaceuticals